We start English website service. Thank you for waiting this.
Immune stimulating material to enhance the efficacy of a vaccine, based on the TLR ligands
Mode of action of adjuvant L-pampo was published in Scientific Reports 2016, “Combination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production”
To improve current vaccine efficacy
To develop novel vaccine
To develop therapeutic vaccine
Improved immunogenicity was demonstrated with HBV, HIV, Flu, TB, Varicella-Zoster vaccines and more